InvestorsHub Logo
Followers 41
Posts 9794
Boards Moderated 0
Alias Born 05/12/2006

Re: Jimbo50 post# 290878

Wednesday, 12/30/2020 6:59:11 PM

Wednesday, December 30, 2020 6:59:11 PM

Post# of 469969
Who is whining...I am merely saying it didn't happen on just a couple occasions...I agree with you...he is funding operations...but that doesn't mean we should pretend that it isn't happening either...

It is a fact that if our drug is approved for "anything" the drug would be worth less than if it was approved without the need to dilute.

Running all of these extra trials does not actually speed up the Rett syndrome trial or any other ongoing trial. Therefore they are unnecessary to run at the moment. He is probably running all of these so that the company is a better buyout target, with a lot of potential revenue on the horizon. There's really no other reason to get your hands into a bunch of these rare diseases pre-revenue if you're so sure that Rett, Parkinson's, and Alzheimer's disease will be approved.

they don't actually have to run any of those trials... They could decide not to and use them on a for increased salaries. people need to wake up and realize all of the things that could be happening not just the ones they want to happen. At the same time, I believe that the money will be spent the way it should.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News